On February 1st, 2024, Law 419/2024 (hereinafter “the Law”) was issued, “which regulates medicines and other human health products and the public procurement of medicines, other human health products, health supplies, medical devices and equipment, and dictates other provisions.”
This law regulates, in general, the manufacture, quality control, sanitary registration, importation, marketing, distribution, acquisition, and information and advertising of products for human health, such as (i) finished medicines, (ii) pharmaceutical specialties, (iii) psychotropic and narcotic drugs, (iv) biological products, (v) drugs developed by genetic engineering, (vi) dietary supplements with therapeutic properties, (vii) homeopathics, (viii) phytopharmaceuticals, (ix) radiopharmaceuticals, (x) medicinal gases, (xi) chemical precursors for medicinal use, (xii) cosmetics, (xiii) pesticides for domestic and public health use, (xiv) antiseptics, (xv) disinfectants for hospital use, (xvi) hygiene products, (xvii) personal hygiene products, and finally, other products related to the health of human beings, except products for veterinary use, which are excluded from this regulation
One of the objectives of the law is to… Read more
